Scenario-Driven Solutions with Verteporfin (SKU A8327) in Ce
2026-05-13
This article provides evidence-based, scenario-driven guidance for deploying Verteporfin (SKU A8327) in cell viability, proliferation, and cytotoxicity assays. By addressing common laboratory challenges with data-backed answers, it demonstrates how Verteporfin delivers reliable results and workflow confidence for biomedical researchers.
Omeprazole (A2845): Technical Guidance for Gastric Acid Rese
2026-05-12
Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor designed for reproducible inhibition of gastric acid secretion in in vitro and ex vivo research settings. Researchers should not use this compound for diagnostic or clinical purposes; its validated utility is limited to mechanistic and pharmacological studies of gastric acid-related disorders.
Birinapant (TL32711): Optimized Workflows for Apoptosis Indu
2026-05-12
Birinapant (TL32711) is redefining apoptosis research by enabling robust, quantifiable activation of cell death pathways in resistant cancer cell models. This guide delivers actionable protocol enhancements, troubleshooting strategies, and translational insight—bridging new biomarker findings to practical laboratory workflows.
Precision Cytotoxicity: Live-Dead Cell Staining Kit I in Mec
2026-05-11
Explore how the Live-Dead Cell Staining Kit I (Calcein AM/PI) empowers advanced mammalian cell viability assays and mechanistic studies of cell death, including ferroptosis in TNBC. This in-depth analysis uniquely connects probe chemistry, workflow design, and translational oncology.
SN-38 Inhibits FUBP1–FUSE Binding: Mechanistic Advances in C
2026-05-11
This article examines new evidence that 7-Ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan, disrupts the FUBP1–FUSE interaction, revealing a novel mechanism beyond topoisomerase I inhibition. These findings suggest expanded strategies for targeting transcriptional regulation and apoptosis in advanced cancer models, notably hepatocellular and colon carcinomas.
Targeting UBE2F-CRL5 Axis for Apoptosis and Radiosensitizati
2026-05-10
Xu et al. present HA-9104, a first-in-class small molecule that selectively inhibits the UBE2F-CRL5 neddylation axis, leading to apoptosis and enhanced radiosensitivity in lung cancer models. Their study refines our understanding of neddylation pathway inhibition and highlights new molecular targets for cancer therapy.
Distinct Apoptotic Pathways in BMECs Induced by Candida krus
2026-05-09
This study uniquely demonstrates that the yeast and hypha forms of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) via separate signaling pathways. By dissecting mitochondrial- and death receptor-mediated mechanisms, the research advances understanding of pathogen-induced mastitis and highlights critical MAPK pathway intersections.
EAGLE-2/EAGLE-3: Gepotidacin vs. Nitrofurantoin in UTI Thera
2026-05-09
The EAGLE-2 and EAGLE-3 phase 3 trials evaluated gepotidacin, a novel triazaacenaphthylene antibiotic, against nitrofurantoin for uncomplicated urinary tract infection in women. Gepotidacin demonstrated non-inferiority and, in one trial, superiority, indicating its clinical potential in the context of rising antimicrobial resistance.
Bismuth Subsalicylate: Applied GI Research Workflows & Insig
2026-05-08
Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) empowers gastrointestinal disorder research with reproducible performance and robust anti-inflammatory action. Discover optimized protocols, troubleshooting strategies, and actionable insights for translational and mechanistic GI studies.
Cy3-dCTP: Advanced Fluorescent DNA Labeling in Molecular Wor
2026-05-07
Cy3-dCTP empowers researchers with direct enzymatic labeling of DNA and cDNA, facilitating high-efficiency fluorescent probe generation for PCR, Nick Translation, and in situ hybridization. This article bridges recent advances in DNA synthesis interfaces with actionable protocol enhancements and troubleshooting strategies, all leveraging APExBIO’s rigorously validated Cyanine 3-deoxycytidine triphosphate.
Methicillin Sodium Salt: Optimizing MSSA Research Workflows
2026-05-07
Methicillin sodium salt from APExBIO empowers precise assay design and robust resistance profiling in Staphylococcus aureus infection research. Discover protocol optimizations, advanced applications, and troubleshooting strategies that maximize data reproducibility in gram-positive bacterial infection models.
Methicillin Sodium Salt (SKU C3238): Reliable Assays in S. a
2026-05-06
This article provides scenario-driven, evidence-based guidance for biomedical researchers optimizing cell viability and antibiotic susceptibility assays using Methicillin sodium salt (SKU C3238). By addressing real-world challenges—from reproducibility to vendor reliability—and integrating current literature, it demonstrates how APExBIO’s Methicillin sodium salt enables robust, data-backed workflows in Staphylococcus aureus infection research.
Neomycin Sulfate: Precision Molecular Disruptor for RNA/DNA
2026-05-06
Explore how Neomycin sulfate, a potent aminoglycoside antibiotic, enables advanced mechanistic studies of RNA/DNA interactions and ion channel function. This article delivers deeper insight into practical assay design, referencing cutting-edge findings and APExBIO's research-grade product.
Protease Inhibitor Cocktail: Elevating Protein Stability in
2026-05-05
Unlock reproducible protein extraction in lipid droplet workflows with the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus). Discover protocol optimizations, troubleshooting insights, and the impact of robust protease inhibition on DFCP1-ATGL studies and metabolic research.
Grazoprevir Hydrate: Optimizing HCV NS3/4A Inhibition Workfl
2026-05-05
Grazoprevir hydrate (MK-5172 hydrate) empowers researchers with robust, picomolar-level inhibition of HCV NS3/4A protease, enabling precise studies across genotypes and challenging patient cohorts. This guide translates recent clinical and bench advances into actionable protocols, troubleshooting strategies, and comparative workflow insights for hepatitis C research.
505 records 22/34 page Previous Next First page 上5页 2122232425 下5页 Last page